SEC Approves NYSE American Rule Targeting Cheap Stocks to Fight Manipulation

2026-08-18 economy

New York, Tuesday, 18 August 2026.
The SEC has approved strict new rules for NYSE American to immediately delist stocks dropping below $0.25, after data revealed 55% fail to recover after 180 days.

Regulatory Mechanics and Suspension Thresholds

The Securities and Exchange Commission issued an order on August 14, 2026, granting accelerated approval for NYSE American to mandate immediate trading suspension for securities closing below $0.25 [4][6]. This rule change amends Section 1003 of the NYSE American Company Guide, bypassing standard delisting procedures found in Section 1009 for these specific cases [1][2]. Under the new framework, the Exchange retains discretionary authority to suspend trading even if a security remains above the $0.25 threshold but experiences a precipitous decline [6][2]. This provision aims to address situations where a security’s price is at an abnormally low level from which recovery is deemed unlikely [1][6].

Empirical Data Supporting Market Integrity

Regulatory analysis of data from 2006 to 2025 indicates that 55% of securities falling below the $0.25 threshold maintained a closing price under that level after 180 days [1][6]. The median closing price for these securities was recorded at $0.23, suggesting limited efficacy for traditional compliance periods [2][6]. Historical peaks in securities falling below this threshold occurred in 2008 with 125 securities, followed by 46 in 2009 and 40 in 2023 [1][6].

Implementation Timeline and Transitional Measures

Although approved in August 2026, the rule is scheduled to become effective on July 1, 2027, providing a transition period for issuers [1][4]. This delay was implemented to allow listed companies time to implement remedial actions, such as reverse stock splits, to increase share prices [2][6]. The original effective date of October 1, 2026, was extended by nine months to address administrative burdens on issuers [4][6].

Stakeholder Concerns and Regulatory Response

Commenters expressed concern that the lack of a cure period violates Section 6(b)(7) of the Act by removing meaningful pre-deprivation process [2][6]. Critics argue that immediate delisting based on a single-day closing price creates persistent delisting risk based on ordinary market volatility [4][6]. Some market participants noted that issuers will face persistent delisting risk without any cure period or meaningful pre-deprivation process [2][6].

Sources

Securities Regulation Stock Exchanges